Teva Pharmaceutical Industries Limited’s TEVA share price has dipped by 13.89%, which has investors questioning if this is ...

The FDA has accepted Alvotech (ALVO) and Teva's (TEVA) applications for AVT05, their proposed biosimilar to J&J's ...

Operator Hello, and welcome to the fourth quarter and full year 2024 Teva Pharmaceutical Industries earnings conference call.

Alvotech and Teva announced FDA acceptance of the Biologics License Application (BLA) for AVT05, a proposed biosimilar ...

We assign Teva a Morningstar Uncertainty Rating of High, which largely reflects our quantitative analysis of the firm, based on the return ranges used by our star rating system, as well as our ...

Teva and Celltrion’s attempt to muscle in ... has hit a setback after the FDA rejected two key biosimilars because of manufacturing problems. The companies filed biosimilars of Roche’s big ...

Medincell receives mid- to high-single digit royalties on all sales and is eligible for $105 million of commercial milestones.

Teva Pharmaceutical Industries Ltd. and Samsung Bioepis Co., Ltd. announced that they entered into a licensing ...

Manhattan Associates said it sees FY2025 adjusted earnings of $4.45 to $4.55 per share, versus market estimates of $4.91 per ...

India's pharmaceutical industry is set for growth, driven by strong market players, global reputation, and evolving trends.